Form 8-K - Current report:
SEC Accession No. 0000896264-25-000213
Filing Date
2025-10-22
Accepted
2025-10-22 16:12:42
Documents
16
Period of Report
2025-10-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K usna-20251022.htm   iXBRL 8-K 27610
2 EX-99.1 ex991earningsreleaseq32025.htm EX-99.1 320676
3 EX-99.2 ex992managementcommentaryq.htm EX-99.2 197591
7 usanacorplogoresized.jpg GRAPHIC 8913
8 usanacorplogoresizeda.jpg GRAPHIC 8913
  Complete submission text file 0000896264-25-000213.txt   730394

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20251022.xsd EX-101.SCH 1776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20251022_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20251022_pre.xml EX-101.PRE 12504
18 EXTRACTED XBRL INSTANCE DOCUMENT usna-20251022_htm.xml XML 2732
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 251410262
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)